ERBB2 and breast carcinoma: Melittin was significantly more potent against HER2-enriched breast cancer and TNBC compared with normal cells.Cytotoxic effect was related to the suppression of activation of EGFR and HER2 by interfering with the phosphorylation of these receptors in the plasma membrane of breast carcinoma cells